LESCOL
Novartis AG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78542452 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Attorney Docket Number | 51653.356.5 |
| Law Office Assigned | L70 |
| Employee Name | HAYASH, SUSAN C |
Timeline
| 2005-01-05 | Application Filed |
| 2005-12-06 | Published for Opposition |
| 2006-02-28 | Location: INTENT TO USE SECTION |
| 2007-08-29 | Abandon |
| 2007-08-29 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | 4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260104 | Circles with two breaks or divided in the middle |
| 270301 | Geometric figures forming letters, numerals or punctuation |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparation for use in lowering cholesterol |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-01-16 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-08-05 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2005-08-06 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2005-08-06 | 4 GNRT F:First Action |
| EXAMINERS AMENDMENT -WRITTEN | 2005-08-08 | 5 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2005-08-08 | 6 GNEA O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2005-08-09 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-08-09 | 8 CNSA P: |
| ASSIGNED TO LIE | 2005-08-12 | 9 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-08-19 | 10 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-11-16 | 11 NPUB O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2005-11-21 | 12 TCCA I:Incoming Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-12-06 | 13 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2006-02-28 | 14 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2006-08-03 | 15 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2006-08-03 | 16 EXT1 S: |
| EXTENSION 1 GRANTED | 2006-08-03 | 17 EX1G S: |
| TEAS EXTENSION RECEIVED | 2007-02-06 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2007-02-06 | 19 EXT2 S: |
| EXTENSION 2 GRANTED | 2007-02-06 | 20 EX2G S: |
| ABANDONMENT - NO USE STATEMENT FILED | 2007-12-07 | 21 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2007-12-17 | 22 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LESCOL 78542452 not registered Dead/Abandoned |
Novartis AG 2005-01-05 |
 LESCOL 75315415 2171358 Dead/Cancelled |
NOVARTIS AG 1997-06-26 |
 LESCOL 74067753 1639501 Live/Registered |
Sandoz Pharmaceuticals Corporation 1990-06-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 